Industry News
Pancreatic Cancer Patients' Choices Easier With New Study
Aug 24, 2012
Almost 45,000 Americans are diagnosed with pancreatic cancer each year. No matter how the disease is treated, it almost always kills within two years after diagnosis, not leaving good odds for those diagnosed. Depending on the stage of the cancer, aggressive intervention with chemotherapy, surgery, or radiation may add an extra month to a year of survival, but unfortunately that is very rare... Read More
PSA Testing For Screening Prostate Cancer Has Improved Survival Rates
Aug 24, 2012
According to a new study published in The Journal of Urology, the introduction of prostate specific antigen (PSA) testing for screening and monitoring prostate cancer has improved survival rates for patients whose disease has metastasized to other areas of the body. In addition, PSA testing has resolved the disparity between African American and Caucasian men. Lead researcher Ian M... Read More
Unique Adverse Events With Newly Approved Drug Reviewed By Melanoma Expert
Aug 24, 2012
An internationally recognized melanoma researcher at Moffitt Cancer Center and colleagues at the University of Kiel in Germany, including Axel Hauschild, M.D., and Katharina C. Kahler, M.D., have published an article in the Journal of Clinical Oncology that describes immune-related adverse events for patients receiving either tremelimumab or ipilimumab... Read More
Intravenous Administration Of Green Tea Compound Shows Promise For Tackling Cancer
Aug 24, 2012
A compound found in green tea could be a weapon in treatments for tackling cancer, according to newly-published research at the University of Strathclyde in Glasgow, Scotland. The extract, known as epigallocatechin gallate, has been known to have preventative anti-cancer properties but fails to reach tumours when delivered by conventional intravenous administration... Read More
Intravenous Administration Of Green Tea Compound Shows Promise For Tackling Cancer
Aug 24, 2012
A compound found in green tea could be a weapon in treatments for tackling cancer, according to newly-published research at the University of Strathclyde in Glasgow, Scotland. The extract, known as epigallocatechin gallate, has been known to have preventative anti-cancer properties but fails to reach tumours when delivered by conventional intravenous administration... Read More
Blood Cells Returned To Stem Cell State
Aug 24, 2012
Johns Hopkins scientists have developed a reliable method to turn the clock back on blood cells, restoring them to a primitive stem cell state from which they can then develop into any other type of cell in the body... Read More
Blood Cells Returned To Stem Cell State
Aug 24, 2012
Johns Hopkins scientists have developed a reliable method to turn the clock back on blood cells, restoring them to a primitive stem cell state from which they can then develop into any other type of cell in the body... Read More
What Is Blood Sugar? What Is Blood Glucose?
Aug 24, 2012
Blood sugar or blood glucose refers to sugar that is transported through the bloodstream to supply energy to all the cells in our bodies. The sugar is made from the food we eat... Read More
What Is Blood Sugar? What Is Blood Glucose?
Aug 24, 2012
Blood sugar or blood glucose refers to sugar that is transported through the bloodstream to supply energy to all the cells in our bodies. The sugar is made from the food we eat... Read More
Cancer Treatment And Prevention By Targeting Inflammation
Aug 24, 2012
Researchers at the Georgia Health Sciences University Cancer Center have identified a gene that disrupts the inflammatory process implicated in liver cancer. Laboratory mice bred without the gene lacked a pro-inflammatory protein called TREM-1 and protected them from developing liver cancer after exposure to carcinogens... Read More
Previous Page Next Page